Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Neurological Therapeutics, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Eur J Neurol. 2020 Jan;27(1):92-99. doi: 10.1111/ene.14038. Epub 2019 Aug 2.
The cervical and thoracic cross-sectional spinal cord area (CS-SCA) in multiple sclerosis (MS) correlates with disability, whilst such a correlation remains to be established in neuromyelitis optica spectrum disorder (NMOSD). Our aim was to clarify differences between MS and NMOSD in spinal cord segments where CS-SCA is associated with disability.
The CS-SCA at C2/C3, C3/C4, T8/T9 and T9/T10 vertebral disc levels was measured in 140 MS patients (111 with relapsing-remitting MS and 29 with progressive MS) and 42 NMOSD patients with anti-aquaporin-4 immunoglobulin G. Disability was evaluated by Expanded Disability Status Scale (EDSS) scores. Multivariate associations between CS-SCA and disability were assessed by stepwise forward multiple linear regression.
Thoracic CS-SCA was significantly smaller in NMOSD patients than in MS patients even after adjusting for age, sex and disease duration (P = 0.002 at T8/T9), whilst there was no difference in cervical CS-SCA between the two diseases. Cervical and thoracic CS-SCA had a negative correlation with EDSS scores in MS patients (P < 0.0001 at C3/C4 and P = 0.0002 at T8/T9) whereas only thoracic CS-SCA correlated with EDSS scores in NMOSD patients (P = 0.0006 at T8/T9). By multiple regression analyses, predictive factors for disability in MS were smaller cervical CS-SCA, progressive course, older age and a higher number of relapses, whilst those in NMOSD were smaller thoracic CS-SCA and older age.
Thoracic CS-SCA is a useful predictive marker for disability in patients with NMOSD whilst cervical CS-SCA is associated with disability in patients with MS.
多发性硬化症(MS)的颈椎和胸段脊髓横截面积(CS-SCA)与残疾相关,而视神经脊髓炎谱系疾病(NMOSD)中这种相关性仍有待确定。我们的目的是阐明与残疾相关的 CS-SCA 脊髓节段中 MS 和 NMOSD 之间的差异。
对 140 例 MS 患者(111 例为复发缓解型 MS,29 例为进展型 MS)和 42 例抗水通道蛋白 4 免疫球蛋白 G 阳性的 NMOSD 患者的 C2/C3、C3/C4、T8/T9 和 T9/T10 椎间盘水平的 CS-SCA 进行了测量。残疾程度采用扩展残疾状态量表(EDSS)评分评估。通过逐步向前多元线性回归评估 CS-SCA 与残疾之间的多变量关联。
即使在调整年龄、性别和疾病持续时间后(T8/T9 时 P=0.002),NMOSD 患者的胸段 CS-SCA 明显小于 MS 患者,而两种疾病的颈段 CS-SCA 无差异。MS 患者的颈段和胸段 CS-SCA 与 EDSS 评分呈负相关(C3/C4 时 P<0.0001,T8/T9 时 P=0.0002),而 NMOSD 患者仅胸段 CS-SCA 与 EDSS 评分相关(T8/T9 时 P=0.0006)。多元回归分析显示,MS 患者残疾的预测因素为较小的颈段 CS-SCA、进行性病程、年龄较大和复发次数较多,而 NMOSD 患者残疾的预测因素为较小的胸段 CS-SCA 和年龄较大。
颈段 CS-SCA 是 MS 患者残疾的有用预测指标,而胸段 CS-SCA 与 NMOSD 患者的残疾相关。